Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$48.89 -0.47 (-0.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) EV to EBIT (2011 - 2026)

Updated

Rigel Pharmaceuticals' (RIGL) EV to EBIT was 7.30 for Q2 2026, up 235.4% from 2.18 a year earlier and up 157.2% from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) EV to EBIT (2011 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Rigel Pharmaceuticals' EV to EBIT came in at 2.26; for FY2025, it was 5.02, down 45.0% from FY2024.

  • By year, EV to EBIT came in at 9.12 in FY2024.
  • The Q2 2026 figure ranks as the highest quarterly EV to EBIT since Q4 2024.
  • Year over year, EV to EBIT gained in 1 of the last four quarters, with growth averaging 13.7%.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 2.84 (Q1 2026), 5.02 (Q4 2025) and 3.17 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Rigel Pharmaceuticals 922.04 Mn 387.93 Mn 70.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.30
Mar 31, 2026 2.84
Dec 31, 2025 5.02
Sep 30, 2025 3.17
Jun 30, 2025 2.18
Mar 31, 2025 5.56
Dec 31, 2024 9.12
Sep 30, 2024 23.56
Mar 31, 2011 9.40
API Access

Rigel Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=RIGL&period=max&api_key=YOUR_API_KEY